Increased proinflammatory markers and lipoperoxidation in obese individuals: Inicial inflammatory events?

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 4, 2015, Pages 280-286

  Ryder, Elena ^a   Pedreañez, Adriana ^a   Vargas, Renata ^a   Peña, Caterina ^a   Fernandez, Erika ^a   Diez Ewald, María ^a   Mosquera, Jesús ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Inflammation; Insulin resistance; Obesity; Oxidative stress

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; AUTACOID; BIOLOGICAL MARKER; INSULIN; LIPID PEROXIDE; TUMOR NECROSIS FACTOR;

ADULT; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; YOUNG ADULT;

ADIPONECTIN; ADULT; BIOMARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; LIPID PEROXIDES; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84988516589     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.04.022     Document Type: Article

References (40)

1. G.M. Reaven The insulin resistance syndrome: definition and dietary approaches to treatment Annu Rev Nutr 25 4 2005 391 406
2. O. Osborn, and J.M. Olefsky The cellular and signaling networks linking the immune system and metabolism in disease Nat Med 18 3 2012 363 374 10.1038/nm.2627
3. G.R. Romeo, J. Lee, and S.E. Shoelson Metabolic syndrome, insulin resistance, and roles of inflammation - mechanisms and therapeutic targets Arterioscler Thromb Vasc Biol 32 8 2012 1771 1776 10.1161/ATVBAHA.111.241869
4. Y. Watanabe, Y. Nagai, and K. Takatsu Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance Nutrients 5 9 2013 3757 3778 10.3390/nu5093757
5. M.A. Cornier, D. Dabelea, T.L. Hernandez, R.C. Lindstrom, A.J. Steig, N.R. Stob, and et al. The metabolic syndrome Endocr Rev 29 7 2008 777 822 10.1210/er.2008-0024
6. P. Dandona, A. Aljada, P. Mohanty, H. Ghanim, W. Hamouda, E. Assian, and et al. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86 7 2001 3257 3265
7. A. Aljada, H. Ghanim, P. Mohanty, N. Kapur, and P. Dandona Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations J Clin Endocrinol Metab 87 3 2002 1419 1422
8. P. Dandona, A. Aljada, P. Mohanty, H. Ghanim, A. Bandyopadhyay, and A. Chaudhuri Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9 Diabetes Care 26 12 2003 3310 3314
9. H. Ghanim, P. Mohanty, R. Deopurkar, C.L. Sia, K. Korzeniewski, S. Abuaysheh, and et al. Acute modulation of toll-like receptors by insulin Diabetes Care 31 9 2008 1827 1831 10.2337/dc08-0561
10. H. Ghanim, K. Korzeniewski, C.L. Sia, S. Abuaysheh, T. Lohano, A. Chaudhuri, and et al. Suppressive effect of insulin infusion on chemokines and chemokine receptors Diabetes Care 33 5 2010 1103 1108 10.2337/dc09-2193
11. F. Armellini, M. Zamboni, L. Rigo, T. Todesco, I.A. Bergamo-Andreis, C. Procacci, and et al. The contribution of sonography to the measurement of intraabdominal fat J Clin Ultrasound 18 7 1990 563 567
12. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assess-ment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 1985 412 419
13. G. Buccini, and D.L. Wolftbal Valores de corte para indices de insulinoresistencia, insulinosensibilidad e insulinosecrecion derivados de la formula HOMA y del programa HOMAZ, Interpretación de los datos Rev Argent Endocrinol Metab 45 2008 3 21
14. M.L. Garmedia, L. Lera, H. Sanchez, R. Vauy, and C. Albala Homeostasis model assessment (HOMA) values in Chilean elderly subjects Rev Med Chile 137 11 2009 1409 1416 S0034-98872009001100001
15. A. Bøyum Isolation of lymphocytes, granulocytes and macrophages Scand J Immunol 5 1976 9 15
16. T. Annadurai, P.A. Thomas, and P. Geraldine Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin-nicotinamide-induced experimental diabetes mellitus Free Radic Res 47 10 2013 793 803 10.3109/10715762.2013.823643
17. J.E. Pessin, and A.R. Saltiel Signaling pathways in insulin action: molecular targets of insulin resistance J Clin Invest 106 2 2000 165 169
18. I. Shimomura, M. Matsuda, R.E. Hammer, Y. Bashmakov, M.S. Brown, and J.L. Goldstein Decreased IRS-2 and increased SREBP-1clead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice Mol Cell 6 1 2000 77 86
19. L. Rui, M. Yuan, D. Frantz, S. Shoelson, and M.F. White SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 J Biol Chem 277 44 2002 42394 42398
20. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 5091 1993 87 91
21. C.H. Lang, C. Dobrescu, and G.J. Bagby Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output Endocrinology 130 1 1992 43 52
22. S.J. Richardson, A. Wilcox, A.J. Bone, A.K. Foulis, and N.G. Morgan Islet-associated macrophages in type 2 diabetes Diabetologia 52 8 2009 1686 1688 10.1007/s00125-009-1410-z [Epub 6 June 2009]
23. J. Spranger, A. Kroke, M. Möhlig, K. Hoffmann, M.M. Bergmann, M. Ristow, and et al. Inflammatory cytokines and the risk to develop type 2 diabetes results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 52 3 2003 812 817
24. M.Y. Donath, D.J. Gross, E. Cerasi, and N. Kaiser Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomysobesus during development of diabetes Diabetes 48 4 1999 738 744
25. J. Quilley Oxidative stress and inflammation in the endothelial dysfunction of obesity: a role for NFκB? J Hypertens 28 10 2010 2010 2011 10.1097/HJH.0b013e32833e24cb
26. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J Clin Invest 117 1 2007 175 184
27. M.F. Hill Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants Curr Cardiol Rev 4 4 2008 259 268
28. A.M. Wolf, D. Wolf, H. Rumpold, B. Enrich, and H. Tlg Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes Biochem Biophys Res Commun 323 2 2004 630 635
29. W.L. Holland, R.A. Miller, Z.V. Wang, K. Sun, B.M. Barth, H.H. Bui, and et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin Nat Med 17 1 2011 55 63
30. P.A. Kern, G.B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor - A expression Diabetes 52 7 2003 1779 1785
31. S. Li, H.J. Shin, E.L. Ding, and R.M. VanDam Adiponectin levels and risk of type2 diabetes: a systematic review and meta-analysis JAMA 302 2 2009 179 188 10.1001/jama.2009.976
32. J.A. Mosquera Role of the receptor for advanced glycation end products (RAGE) in inflammation Invest Clin 51 2 2010 257 268
33. P.C. Underwood, and G.K. Adler The renin angiotensin aldosterone system and insulin resistance in humans Curr Hypertens Rep 15 1 2013 59 70 10.1007/s11906-012-0323-2
34. P. Saint-Marc, L.P. Kozak, G. Ailhaud, C. Darimont, and R. Negrel Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation Endocrinology 142 1 2001 487 492
35. H.A. Pershadsingh, and T.W. Kurtz Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease Diabetes Care 27 4 2004 1015
36. P.J. Barnes, and M. Karin Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 15 1997 1066 1071
37. L. Wu, and L. Van Kaer Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance Adipocyte 2 1 2013 12 16
38. P.S. Patel, E.D. Buras, and A. Balasubramanyam The role of the immune system in obesity and insulin resistance J Obesity 2013 2013 616193 10.1155/2013/616193
39. E. Ferrannini, A. Natali, P. Bell, P. Cavallo-Perin, N. Lalic, and G. Mingrone Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR) J Clin Invest 100 5 1997 1166 1173
40. A.D. Karelis, M. Faraj, J.P. Bastard, D.H. St-Pierre, M. Brochu, D. Prud'homme, and et al. The metabolically healthy but obese individual presents a favorable inflammation proflle J Clin Endocrinol Metab 90 7 2005 4145 4150